Loading...

PE/Cyanine7 anti-mouse CD127 (IL-7Rα) Antibody

Pricing & Availability
Clone
A7R34 (See other available formats)
Regulatory Status
RUO
Other Names
IL-7 receptor α chain, IL-7Rα
Isotype
Rat IgG2a, κ
Ave. Rating
Submit a Review
Product Citations
publications
A7R34_PECyanine7_CD127_Antibody_1_022624
C57BL/6 mouse splenocytes stained with CD3ε (clone 145-2C11) FITC and CD127 (clone A7R34) PE/Cyanine7 (left) or rat IgG2a, κ isotype control (bottom).
  • A7R34_PECyanine7_CD127_Antibody_1_022624
    C57BL/6 mouse splenocytes stained with CD3ε (clone 145-2C11) FITC and CD127 (clone A7R34) PE/Cyanine7 (left) or rat IgG2a, κ isotype control (bottom).
Compare all formats See PE/Cyanine7 spectral data
Cat # Size Price Quantity Check Availability Save
135013 25 µg £80
Check Availability


Need larger quantities of this item?
Request Bulk Quote
135014 100 µg £241
Check Availability


Need larger quantities of this item?
Request Bulk Quote
Description

CD127 is a 60-90 kD type I transmembrane glycoprotein also known as IL-7 receptor α chain or IL-7Rα. It forms a heterodimer with the common γ chain (γc or CD132) which is shared with the receptors for IL-2, IL-4, IL-9, IL-13, IL-15, and IL-21. CD127 is expressed on immature B cells through early pre-B stage, thymocytes (except CD4/CD8 double positive thymocytes), peripheral T cells, and bone marrow stromal cells. CD127 has been reported to be an useful marker for identifying memory and effector T cells. The ligation of IL-7 with its receptor is important for stimulation of mature and immature T cells as well as immature B cells proliferation and development.

Product Details
Technical Data Sheet (pdf)

Product Details

Verified Reactivity
Mouse
Antibody Type
Monoclonal
Host Species
Rat
Immunogen
IL-7Ra-IgG1 fusion protein
Formulation
Phosphate-buffered solution, pH 7.2, containing 0.09% sodium azide.
Preparation
The antibody was purified by affinity chromatography, and conjugated with PE/Cyanine7 under optimal conditions.
Concentration
0.2 mg/ml
Storage & Handling
The antibody solution should be stored undiluted between 2°C and 8°C, and protected from prolonged exposure to light. Do not freeze.
Application

FC - Quality tested
Recommended Usage

Each lot of this antibody is quality control tested by immunofluorescent staining with flow cytometric analysis. For flow cytometric staining, the suggested use of this reagent is ≤1.0 µg per million cells in 100 µl volume. It is recommended that the reagent be titrated for optimal performance for each application.

Excitation Laser
Blue Laser (488 nm)
Green Laser (532 nm)/Yellow-Green Laser (561 nm)
Application Notes

A7R34 is able to block clone SB/199 binding to IL-7R.

Application References

(PubMed link indicates BioLegend citation)
  1. Sudo T, et al. 1993. P. Natl. Acad. Sci. USA 90:9125.
  2. Hashi H, et al. 2001. J. Immunol. 166:3702.
  3. Taylor R, et al. 2007. J. Immunol. 178:5659.
  4. Mazzon C, et al. 2011. Blood. 118:2733. PubMed
  5. Jin J, et al. 2011. J. Immunol. doi:10.4049/jimmunol.1001238. PubMed
Product Citations
  1. Zheng X, et al. 2019. PLoS Pathog. 15:e1008036. PubMed
  2. Christian DA, et al. 2022. Sci Immunol. 7:eabq7432. PubMed
  3. Zander R, et al. 2022. Elife. 11:. PubMed
  4. Hutter K, et al. 2022. Front Immunol. 13:967914. PubMed
  5. Zhang H, et al. 2022. Eur J Immunol. 52:978. PubMed
  6. Chakraborty P, et al. 2022. Cancer Res. 82:1969. PubMed
  7. Shallberg LA, et al. 2022. PLoS Pathog. 18:e1010296. PubMed
  8. Kraemer AN, et al. 2022. Front Immunol. 13:933191. PubMed
  9. Horkova V, et al. 2023. Nat Immunol. 24:174. PubMed
  10. Giannou AD, et al. 2023. Immunity. 56:125. PubMed
  11. Gonçalves R, et al. 2023. iScience. 26:105972. PubMed
  12. Scherer S, et al. 2023. Nat Immunol. 24:501. PubMed
  13. Feng J, et al. 2022. Immunity. 55:405. PubMed
  14. Zander R, et al. 2022. Immunity. 55:475. PubMed
  15. Ye B, et al. 2022. Cell Mol Immunol. 19:619. PubMed
  16. Page N, et al. 2018. Immunity. 48:937. PubMed
  17. Baptista AP et al. 2019. Immunity. 50(5):1188-1201 . PubMed
  18. Delás MJ, et al. 2019. Cell Rep. 27:719. PubMed
  19. Pokrovskii M, et al. 2019. Immunity. 51:185. PubMed
  20. Yamamoto R et al. 2018. Cell stem cell. 22(4):600-607 . PubMed
  21. Oda SK, et al. 2020. J Exp Med. 217: . PubMed
  22. LaFleur MW, et al. 2019. Nat Immunol. 20:1335. PubMed
  23. Paiva RS, et al. 2021. Eur J Immunol. 51:1968. PubMed
  24. Shimokawa C et al. 2017. Immunity. 46(5):863-874 . PubMed
  25. Ramos CV, et al. 2020. Cell Reports. 32(3):107910. PubMed
  26. Zhang B, et al. 2022. J Exp Med. 219:. PubMed
  27. Paiva RA, et al. 2021. Cell Reports. 35(2):108967. PubMed
  28. Hurrell BP, et al. 2019. Cell Rep. 29:4509. PubMed
  29. He X, et al. 2021. Adv Sci (Weinh). 8:e2103023. PubMed
  30. Xu H, et al. 2020. Immunity. 51(4):696-708.e9.. PubMed
  31. Reismann D, et al. 2017. Nat Commun.. 10.1038/s41467-017-01538-9. PubMed
  32. LaFleur MW, et al. 2019. Nat Commun. 10:1668. PubMed
  33. Oka Y, et al. 2020. Sci Adv. 6:. PubMed
  34. Galle-Treger L, et al. 2020. J Allergy Clin Immunol. 145:502. PubMed
  35. Shafiei-Jahani P, et al. 2021. Nat Commun. 12:2526. PubMed
  36. Galle-Treger L, et al. 2016. Nat Commun. 7:13202. PubMed
  37. Galle-Treger L, et al. 2019. Nat Commun. 10:713. PubMed
  38. Toshiro Hirai et al. 2019. Immunity. 50(5):1249-1261 . PubMed
  39. Olguín JE, et al. 2018. J Cancer. 9:239. PubMed
  40. Fang H, et al. 2020. Nat Commun. 4.661805556. PubMed
  41. Dahlgren MW et al. 2019. Immunity. 50(3):707-722 . PubMed
  42. Lehrke MJ, et al. 2021. Elife. 10:. PubMed
  43. Nagashima H et al. 2019. Immunity. 51(4):682-695 . PubMed
  44. Omatsu Y, et al. 2022. Nat Commun. 13:2654. PubMed
  45. Richardson ET, et al. 2015. PLoS One. 10: 1371. PubMed
  46. Amezcua Vesely MC, et al. 2020. Cell. 178(5):1176-1188.e15.. PubMed
  47. Mah-Som AY, et al. 2021. Cell Reports. 35(9):109209. PubMed
  48. Satoh–Takayama N, et al. 2020. Immunity. 52(4):635-649. PubMed
  49. Chao JL, et al. 2021. Cell Rep Med. 2:100399. PubMed
  50. Zhong C, et al. 2020. Immunity. 52(1):83-95.e4.. PubMed
  51. Chetty A, et al. 2021. Cell Host Microbe. 29:579. PubMed
  52. Radulovic V, et al. 2020. Cell Reports. 27(10):2826-2836.e5.. PubMed
  53. Goc J, et al. 2021. Cell. 184:5015. PubMed
  54. Zander R, et al. 2020. Immunity. 51(6):1028-1042.e4.. PubMed
  55. Liu Y, et al. 2021. Nat Commun. 12:6831. PubMed
RRID
AB_1937265 (BioLegend Cat. No. 135013)
AB_1937265 (BioLegend Cat. No. 135014)

Antigen Details

Structure
Type I transmembrane glycoprotein, associate with CD132, 60-90 kD
Distribution

Immature B cells through early pre-B stage, thymocytes (except CD4/CD8 double positive thymocytes), peripheral T cells, bone marrow stromal cells

Function
T cell and immature B cell proliferation and development
Ligand/Receptor
IL-7
Cell Type
B cells, T cells, Thymocytes
Biology Area
Immunology
Molecular Family
CD Molecules, Cytokine/Chemokine Receptors
Antigen References

1. Sudo T, et al. 1993. P. Natl. Acad. Sci. USA 90:9125.
2. Okuno Y, et al. 2001. P. Natl. Acad. Sci. USA 99:6246.
3. Pillai M, et al. 2004. Leukemia Lymphoma 45:2403.

Gene ID
16197 View all products for this Gene ID
Specificity (DOES NOT SHOW ON TDS):
CD127
Specificity Alt (DOES NOT SHOW ON TDS):
CD127
App Abbreviation (DOES NOT SHOW ON TDS):
FC
UniProt
View information about CD127 on UniProt.org

Related FAQs

There are no FAQs for this product.
Go To Top Version: 1    Revision Date: 11/30/2012

For Research Use Only. Not for diagnostic or therapeutic use.

 

This product is supplied subject to the terms and conditions, including the limited license, located at www.biolegend.com/terms) ("Terms") and may be used only as provided in the Terms. Without limiting the foregoing, BioLegend products may not be used for any Commercial Purpose as defined in the Terms, resold in any form, used in manufacturing, or reverse engineered, sequenced, or otherwise studied or used to learn its design or composition without express written approval of BioLegend. Regardless of the information given in this document, user is solely responsible for determining any license requirements necessary for user’s intended use and assumes all risk and liability arising from use of the product. BioLegend is not responsible for patent infringement or any other risks or liabilities whatsoever resulting from the use of its products.

 

BioLegend, the BioLegend logo, and all other trademarks are property of BioLegend, Inc. or their respective owners, and all rights are reserved.

 

8999 BioLegend Way, San Diego, CA 92121 www.biolegend.com
Toll-Free Phone: 1-877-Bio-Legend (246-5343) Phone: (858) 768-5800 Fax: (877) 455-9587

This data display is provided for general comparisons between formats.
Your actual data may vary due to variations in samples, target cells, instruments and their settings, staining conditions, and other factors.
If you need assistance with selecting the best format contact our expert technical support team.

ProductsHere
Login / Register
Remember me
Forgot your password? Reset password?
Create an Account